Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 532

1.

Interstitial lung pathology: should we test for autoantibodies to cellular antigens?

Serelis J, Athanasakos A, Skopouli FN, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 Dec 20. [Epub ahead of print] No abstract available.

PMID:
30620288
2.

Dapsone: an old drug effective for subacute cutaneous lupus erythematosus.

Zampeli E, Moutsopoulos HM.

Rheumatology (Oxford). 2019 Jan 4. doi: 10.1093/rheumatology/key434. [Epub ahead of print] No abstract available.

PMID:
30615176
3.

Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.

Karagianni P, Nezos A, Ioakeim F, Tzioufas AG, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 Nov-Dec;36 Suppl 115(6):86-89. Epub 2018 Nov 9.

PMID:
30418111
4.

Autoantibodies to ox-LDL in Sjögren's syndrome: are they atheroprotective?

Cinoku I, Mavragani CP, Tellis CC, Nezos A, Tselepis AD, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):61-67. Epub 2018 Aug 13.

5.

Severe cutaneous hand infection: Mycobacterium marinum in an immunosuppressed patient.

Argyropoulou OD, Zampeli E, Sipsas NV, Tzioufas AG, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):1117. Epub 2018 Jul 19. No abstract available.

6.

Myositis autoantibody profiles and their clinical associations in Greek patients with inflammatory myopathies.

Zampeli E, Venetsanopoulou A, Argyropoulou OD, Mavragani CP, Tektonidou MG, Vlachoyiannopoulos PG, Tzioufas AG, Skopouli FN, Moutsopoulos HM.

Clin Rheumatol. 2018 Aug 25. doi: 10.1007/s10067-018-4267-z. [Epub ahead of print]

PMID:
30145635
7.

Keratoderma Blenorrhagica.

Zampeli E, Moutsopoulos HM.

Arthritis Rheumatol. 2018 Dec;70(12):2056. doi: 10.1002/art.40689. Epub 2018 Oct 22. No abstract available.

PMID:
30101429
8.

Tongue Atrophy in Sjögren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands?

Zampeli E, Kalogirou EM, Piperi E, Mavragani CP, Moutsopoulos HM.

J Rheumatol. 2018 Nov;45(11):1565-1571. doi: 10.3899/jrheum.180101. Epub 2018 Jul 15.

PMID:
30008454
9.

Natural Autoantibodies: An Undersugn Hero of the Immune System and Autoimmune Disorders-A Point of View.

Avrameas S, Alexopoulos H, Moutsopoulos HM.

Front Immunol. 2018 Jun 12;9:1320. doi: 10.3389/fimmu.2018.01320. eCollection 2018. No abstract available.

10.

B-cell activating factor and related genetic variants in lupus related atherosclerosis.

Theodorou E, Nezos A, Antypa E, Ioakeimidis D, Koutsilieris M, Tektonidou M, Moutsopoulos HM, Mavragani CP.

J Autoimmun. 2018 Aug;92:87-92. doi: 10.1016/j.jaut.2018.05.002. Epub 2018 May 31.

PMID:
29859654
11.

Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome.

Zampeli E, Skopouli FN, Moutsopoulos HM.

J Rheumatol. 2018 Jun;45(6):877-878. doi: 10.3899/jrheum.171296. No abstract available.

PMID:
29858460
12.

Sjögren's syndrome: disease activity indexes! Do they make us better clinicians or technicians?

Moutsopoulos HM, Skopouli FN.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):29-30. Epub 2018 May 25. No abstract available.

13.

Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren's syndrome.

Kampolis CF, Fragkioudaki S, Mavragani CP, Zormpala A, Samakovli A, Moutsopoulos HM.

Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):94-101. Epub 2018 May 29.

14.

Relapsing polychondritis: a diagnosis not to be missed.

Zampeli E, Moutsopoulos HM.

Rheumatology (Oxford). 2018 Oct 1;57(10):1768. doi: 10.1093/rheumatology/key124. No abstract available.

PMID:
29718381
15.

Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis.

Giannelou M, Nezos A, Fragkioudaki S, Kasara D, Maselou K, Drakoulis N, Ioakeimidis D, Moutsopoulos HM, Mavragani CP.

Clin Immunol. 2018 Aug;193:110-117. doi: 10.1016/j.clim.2018.02.014. Epub 2018 Mar 6.

PMID:
29501539
16.

Evolution from one autoimmune disorder to another. Epitope spreading?

Karagianni P, Zampeli E, Moutsopoulos HM.

Scand J Immunol. 2018 May;87(5):e12657. doi: 10.1111/sji.12657. Epub 2018 Mar 25. No abstract available.

PMID:
29486064
17.

The oral mucosa: A barrier site participating in tissue-specific and systemic immunity.

Moutsopoulos NM, Moutsopoulos HM.

Oral Dis. 2018 Mar;24(1-2):22-25. doi: 10.1111/odi.12729.

PMID:
29480644
18.

Pauci-immune crescentic glomerulonephritis in a patient with B-lymphocyte poly/autoreactivity.

Moutsopoulos HM, Gakiopoulou H.

Clin Exp Rheumatol. 2018 Mar-Apr;36(2):344. Epub 2018 Jan 31. No abstract available.

PMID:
29465375
19.

Stress and Disease Onset in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Golemati CV, Mavragani CP, Lionaki S, Karaiskos D, Moutsopoulos HM.

Front Psychiatry. 2017 Dec 15;8:286. doi: 10.3389/fpsyt.2017.00286. eCollection 2017.

20.

Rapidly progressive lung disease in a patient with signs of clinically amyopathic dermatomyositis.

Zampeli E, Skopouli FN, Athanasakos A, Moutsopoulos HM.

Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1057-1058. Epub 2017 Sep 15. No abstract available.

PMID:
28980902
21.

Type I interferonopathy in a young adult.

Manoussakis MN, Mavragani CP, Nezos A, Zampeli E, Germenis A, Moutsopoulos HM.

Rheumatology (Oxford). 2017 Dec 1;56(12):2241-2243. doi: 10.1093/rheumatology/kex316. No abstract available.

PMID:
28968819
22.

Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.

Nezos A, Cinoku I, Mavragani CP, Moutsopoulos HM.

Clin Immunol. 2017 Oct;183:300-303. doi: 10.1016/j.clim.2017.09.012. Epub 2017 Sep 14.

PMID:
28919520
23.

Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study.

Fragoulis GE, Lionaki S, Venetsanopoulou A, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzioufas AG.

Clin Rheumatol. 2018 Mar;37(3):737-747. doi: 10.1007/s10067-017-3835-y. Epub 2017 Sep 15.

PMID:
28914375
24.

MTHFR gene variants and non-MALT lymphoma development in primary Sjogren's syndrome.

Fragkioudaki S, Nezos A, Souliotis VL, Chatziandreou I, Saetta AA, Drakoulis N, Tzioufas AG, Voulgarelis M, Sfikakis PP, Koutsilieris M, Crow MK, Moutsopoulos HM, Mavragani CP.

Sci Rep. 2017 Aug 4;7(1):7354. doi: 10.1038/s41598-017-07347-w.

25.

Livedoid Vasculopathy.

Zampeli E, Moutsopoulos HM.

Arthritis Rheumatol. 2017 Oct;69(10):2096. doi: 10.1002/art.40153. Epub 2017 Aug 15. No abstract available.

26.

Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study.

Lampropoulos CE, Orfanos P, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2017 Mar-Apr;35(2):192-200. Epub 2017 Jan 16.

PMID:
28094760
27.

A comprehensive evaluation for the treatment of lupus nephritis.

Zampeli E, Klinman DM, Gershwin ME, Moutsopoulos HM.

J Autoimmun. 2017 Mar;78:1-10. doi: 10.1016/j.jaut.2016.12.011. Epub 2017 Jan 9. Review.

PMID:
28082046
28.

IgG4-Related Nodular Lung Lesion.

Skopouli FN, Panayotopoulos P, Moutsopoulos HM.

Arthritis Rheumatol. 2017 Feb;69(2):438. doi: 10.1002/art.39994. No abstract available.

29.

Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores.

Vlachogiannis NI, Nezos A, Tzioufas AG, Koutsilieris M, Moutsopoulos HM, Mavragani CP.

Clin Immunol. 2016 Dec;173:157-160. doi: 10.1016/j.clim.2016.10.015. Epub 2016 Nov 1.

PMID:
27810512
30.

IgG4-Related Orbital Disease Presenting With Unilateral Eyelid Swelling.

Zampeli E, Moutsopoulos HM.

Arthritis Rheumatol. 2016 Nov;68(11):2824. doi: 10.1002/art.39836. No abstract available.

31.

Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.

Mavragani CP, Sagalovskiy I, Guo Q, Nezos A, Kapsogeorgou EK, Lu P, Liang Zhou J, Kirou KA, Seshan SV, Moutsopoulos HM, Crow MK.

Arthritis Rheumatol. 2016 Nov;68(11):2686-2696. doi: 10.1002/art.39795.

32.

Chest Pain in a 39-Year-Old Man: What Could Be the Underlying Cause?

Plastiras SC, Zampeli E, Moutsopoulos HM.

Am J Med. 2016 Dec;129(12):e329-e330. doi: 10.1016/j.amjmed.2016.07.001. Epub 2016 Jul 9. No abstract available.

PMID:
27403601
33.

Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome.

Fragoulis GE, Fragkioudaki S, Reilly JH, Kerr SC, McInnes IB, Moutsopoulos HM.

J Autoimmun. 2016 Sep;73:85-91. doi: 10.1016/j.jaut.2016.06.008. Epub 2016 Jun 22.

PMID:
27344240
34.

Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.

Fragkioudaki S, Mavragani CP, Moutsopoulos HM.

Medicine (Baltimore). 2016 Jun;95(25):e3766. doi: 10.1097/MD.0000000000003766.

35.

IgG4-related sialadenitis and Sjögren's syndrome.

Fragoulis GE, Zampeli E, Moutsopoulos HM.

Oral Dis. 2017 Mar;23(2):152-156. doi: 10.1111/odi.12526. Epub 2016 Jul 14. Review.

PMID:
27318181
36.

Predictors of renal histopathology in antineutrophil cytoplasmic antibody associated glomerulonephritis.

Lionaki S, Mavragani CP, Karras A, Liapis G, Somarakis G, Boletis JN, Drosos A, Tzioufas AG, Guillevin L, Moutsopoulos HM.

J Autoimmun. 2016 Aug;72:57-64. doi: 10.1016/j.jaut.2016.05.004. Epub 2016 May 15.

PMID:
27194577
37.

Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations.

Kampylafka EI, Alexopoulos H, Fouka P, Moutsopoulos HM, Dalakas MC, Tzioufas AG.

Lupus. 2016 Oct;25(11):1260-5. doi: 10.1177/0961203316636473. Epub 2016 Feb 27.

PMID:
26923281
38.

Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.

Gupta S, Tatouli IP, Rosen LB, Hasni S, Alevizos I, Manna ZG, Rivera J, Jiang C, Siegel RM, Holland SM, Moutsopoulos HM, Browne SK.

Arthritis Rheumatol. 2016 Jul;68(7):1677-87. doi: 10.1002/art.39607.

39.

Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.

Alexopoulos H, Kampylafka EI, Fouka P, Tatouli I, Akrivou S, Politis PK, Moutsopoulos HM, Tzioufas AG, Dalakas MC.

J Neuroimmunol. 2015 Dec 15;289:8-11. doi: 10.1016/j.jneuroim.2015.10.007. Epub 2015 Oct 13.

PMID:
26616866
40.

Fatigue in Primary Sjögren's Syndrome: Clinical, Laboratory, Psychometric, and Biologic Associations.

Karageorgas T, Fragioudaki S, Nezos A, Karaiskos D, Moutsopoulos HM, Mavragani CP.

Arthritis Care Res (Hoboken). 2016 Jan;68(1):123-31. doi: 10.1002/acr.22720.

41.

Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.

Patsouras MD, Sikara MP, Grika EP, Moutsopoulos HM, Tzioufas AG, Vlachoyiannopoulos PG.

J Autoimmun. 2015 Dec;65:30-7. doi: 10.1016/j.jaut.2015.08.001. Epub 2015 Aug 15.

PMID:
26283469
42.

A tribute to Norman Talal.

Moutsopoulos HM, Talal M, Plotz PH.

J Clin Invest. 2015 Aug 3;125(8):2910-1. doi: 10.1172/JCI83241. Epub 2015 Jul 13. No abstract available.

43.

A BAFF receptor His159Tyr mutation in Sjögren's syndrome-related lymphoproliferation.

Papageorgiou A, Mavragani CP, Nezos A, Zintzaras E, Quartuccio L, De Vita S, Koutsilieris M, Tzioufas AG, Moutsopoulos HM, Voulgarelis M.

Arthritis Rheumatol. 2015 Oct;67(10):2732-41. doi: 10.1002/art.39231.

44.

Professor Norman Talal 1934-2015.

Moutsopoulos HM, Sugai S, Sawada S, Koike T, Miyasaka N, Kobayashi S, Takei M, Ogawa N.

Mod Rheumatol. 2015 Jul;25(4):664. doi: 10.3109/14397595.2015.1052683. No abstract available.

PMID:
26095110
45.

Clinical and laboratory predictors of distinct histopathogical features of lupus nephritis.

Mavragani CP, Fragoulis GE, Somarakis G, Drosos A, Tzioufas AG, Moutsopoulos HM.

Medicine (Baltimore). 2015 May;94(21):e829. doi: 10.1097/MD.0000000000000829.

46.

Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren's syndrome: prevalence, clinical and laboratory associations.

Gravani F, Papadaki I, Antypa E, Nezos A, Masselou K, Ioakeimidis D, Koutsilieris M, Moutsopoulos HM, Mavragani CP.

Arthritis Res Ther. 2015 Apr 11;17:99. doi: 10.1186/s13075-015-0613-6.

47.

Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.

Papageorgiou A, Ziogas DC, Mavragani CP, Zintzaras E, Tzioufas AG, Moutsopoulos HM, Voulgarelis M.

PLoS One. 2015 Feb 27;10(2):e0116189. doi: 10.1371/journal.pone.0116189. eCollection 2015.

48.

Adverse events and infections in patients with rheumatoid arthritis treated with conventional drugs or biologic agents: a real world study.

Lampropoulos CE, Orfanos P, Bournia VK, Karatsourakis T, Mavragani C, Pikazis D, Manoussakis MN, Tzioufas AG, Moutsopoulos HM, Vlachoyiannopoulos PG.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):216-24. Epub 2015 Feb 9.

PMID:
25664400
49.

Impaired clearance of early apoptotic cells mediated by inhibitory IgG antibodies in patients with primary Sjögren's syndrome.

Manoussakis MN, Fragoulis GE, Vakrakou AG, Moutsopoulos HM.

PLoS One. 2014 Nov 14;9(11):e112100. doi: 10.1371/journal.pone.0112100. eCollection 2014.

50.

Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study.

Kosmidis ML, Koutsogeorgopoulou L, Alexopoulos H, Mamali I, Vlachoyiannopoulos PG, Voulgarelis M, Moutsopoulos HM, Tzioufas AG, Dalakas MC.

J Neurol Sci. 2014 Dec 15;347(1-2):143-7. doi: 10.1016/j.jns.2014.09.035. Epub 2014 Sep 28.

PMID:
25304055

Supplemental Content

Loading ...
Support Center